
Explore the digital therapeutics (DTx) market. This analysis covers market size, growth trends, key drivers, regulatory frameworks, and future outlook for 2025.
Explore the digital therapeutics (DTx) market. This analysis covers market size, growth trends, key drivers, regulatory frameworks, and future outlook for 2025.
Learn about the EU AI Act's impact on pharma. This guide explains the risk-based approach, high-risk AI rules, and compliance steps with a free flowchart & SOP
Explore 2025 data on AI adoption in U.S. hospitals. This report covers key statistics, use cases like sepsis detection, EHR integration, and adoption disparitie
A technical comparison of Databricks vs. Snowflake for life sciences. Explore the lakehouse and cloud data platform for genomics, clinical data, and AI/ML workl
An analysis of GLM-4.6, the leading open-source coding model. Compare its benchmarks against Anthropic's Sonnet and OpenAI's GPT-5, and learn its hardware needs
An in-depth 2025 analysis of the leading medical imaging and digital pathology AI vendors. Covers market size, deep learning trends, and top company profiles.
Our 2025 report analyzes the critical AI skills gap in the pharmaceutical industry, detailing the talent shortage with data and exploring key solutions.
An in-depth guide to IT system assessment in pharma M&A due diligence. Explore key review areas like infrastructure, data, security, and compliance to avoid cos
Explore a detailed cost-benefit analysis of RTSM implementation in clinical trials. Learn how RTSM systems reduce drug waste by 15-30% and save millions.
Learn how target trial emulation provides a structured framework for drawing causal inference from real-world evidence (RWE) to support healthcare decisions.
Explore biotech salary trends across global regions. This data-driven analysis compares pay in top hubs like the US & Switzerland and details cost-of-living imp
In-depth Epic vs Cerner AI analysis. Compare how each EHR leader uses generative AI, predictive analytics, and voice tools to improve clinical workflows.
Learn the GAMP 5 software categories for computerized system validation. This guide explains each category with examples and its role in a risk-based approach.
A comprehensive guide to lab equipment qualification (IQ/OQ/PQ). Learn the process, regulatory standards, and how automation streamlines validation and complian
An in-depth review of Certara's drug development software suite for MIDD. Learn about Phoenix WinNonlin for PK/PD, the Simcyp PBPK Simulator, and QSP tools.
Learn the key differences between GAMP 4 and GAMP 5. This guide for pharma IT covers the shift to risk-based validation and provides a clear migration path.
Explore a data-driven profile of Peter Gassner, the founder of Veeva Systems. Learn about his career, Veeva's vertical SaaS strategy, and its growth.
Learn about Japan's PMDA regulatory pathways for drug approval under the PMD Act. This guide covers standard and expedited options like Sakigake and Orphan Drug
Understand the ICH M7 guideline for assessing and controlling mutagenic impurities in pharmaceuticals using in silico (Q)SAR software, TTC, and risk-based metho
A detailed analysis of the global pharmaceutical market, forecast to reach $1.6T by 2025. Explore key growth drivers, therapy areas, and industry challenges.
An in-depth study of pharmacy management systems. Explore key software features for dispensing, inventory, and billing, and compare top vendors in the market.
Learn about Patient-Reported Outcomes (PRO) systems in clinical trials. This guide covers ePRO data collection, PROMs, FDA regulatory guidelines, and challenges
An educational overview of AI-assisted surgery, profiling top companies like Intuitive Surgical, Medtronic, and J&J. Learn about robotic platforms and market da
This analysis examines the 2019 Veeva Crossix acquisition, detailing the integration of patient data with Veeva CRM and its impact on pharma marketing analytics
I personally work with pharma and biotech companies to build custom AI-powered software. Software development costs have dropped significantly this year—let's discuss how I can help bring your ideas to life.